A Study To Assess The Effects Of A Single Dose Of GSK598809 In Modulating Nicotine Reward

Clinical trial NCT00605241 · COMPLETED

Trial details

NCT number: NCT00605241
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Substance Dependence

Start date: 2008-02-25
Primary completion: 2009-03-20
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.